ArticleJournal of blood medicine2020

Good Profile of Efficacy/Tolerance of Bortezomib or Idelalisib in Waldenström Macroglobulinemia Associated with Acquired Von Willebrand Syndrome.

Mario Ojeda-Uribe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.